Air Tanzania and Kenya Airways explore cargo partnership

Air Tanzania and Kenya Airways explore cargo partnership

Dar es Salaam. Air Tanzania Company Limited (ATCL) and Kenya Airways (KQ) top officials have met in an attempt to explore the possibility of a partnership on cargo transportation.

This comes as ATCL expects to receive its first Boeing 767-300 freighter, with a capacity of 54 tonnes, by the end of this month.

KQ Group managing director Allan Kilavuka, who visited Tanzania recently, said in a statement released by ATCL yesterday that the two airlines could cooperate in different areas.

“Soon Tanzania will receive its first ever cargo plane, which we expect will help in addressing cargo transportation challenges, especially at large volumes,” he said.

“From the available freight, equipment, and expertise, if used properly, we will increase the value and reduce the operating costs of both ATCL and KQ. The presence of the Boeing 787-8 (Dreamliner) and the arrival of the Boeing 767-300F cargo plane open up more commercial opportunities,” said Mr Kilavuka.

According to ATCL’s managing director, Mr Ladislaus Matindi, during Mr Kilavuka’s visit, they held a meeting where they looked at the issues that will help the prosperity of the two airlines and their countries, considering the great needs of the world market.

He mentioned the areas intended to cooperate include the exchange of expertise and conducting practical training without relying on foreign countries in order to increase operational efficiency.

“The African market alone is very large and requires cooperation to exploit it, especially the service of transporting passengers and cargo,” said Mr Matindi.

“We also talked about getting practical training, which now necessitates sending experts to nations throughout Europe for two or three days of training. If this education can be found in the neighbouring countries, it will be better to raise the capacity of the two companies and bring more productivity to the society around them,” he said.

According to him, the expected cargo plane will come at the right time as demand continues to rise due to growing trade and commercial activities.

Apart from perishable products, other items expected to be transported from Tanzania include general cargo services, chicks and fish, pharma services, newspapers and magazines, valuable cargo, express parcels, postal and courier services, dangerous goods and human remains.

Original Media Source

Share this news

Facebook
Twitter
LinkedIn
WhatsApp

This Year's Most Read News Stories

Tanzania Confirms Outbreak of Marburg Virus Disease
Tanzania Foreign Investment News
Chief Editor

Tanzania Confirms Outbreak of Marburg Virus Disease

Dodoma — Tanzania today confirmed an outbreak of Marburg virus disease in the northwestern Kagera region after one case tested positive for the virus following investigations and laboratory analysis of suspected cases of the disease.

President of the Republic of Tanzania, Her Excellency Samia Suluhu Hassan, made the announcement during a press briefing alongside World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, in the country’s administrative capital Dodoma.

“Laboratory tests conducted in Kabaile Mobile Laboratory in Kagera and later confirmed in Dar es Salaam identified one patient as being infected with the Marburg virus. Fortunately, the remaining suspected patients tested negative,” the president said. “We have demonstrated in the past our ability to contain a similar outbreak and are determined to do the same this time around.”

A total of 25 suspected cases have been reported as of 20 January 2025, all of whom have tested negative and are currently under close follow-up, the president said. The cases have been reported in Biharamulo and Muleba districts in Kagera.

“We have resolved to reassure the general public in Tanzania and the international community as a whole of our collective determination to address the global health challenges, including the Marburg virus disease,” said H.E President Hassan.

WHO is supporting Tanzanian health authorities to enhance key outbreak control measures including disease surveillance, testing, treatment, infection prevention and control, case management, as well as increasing public awareness among communities to prevent further spread of the virus.

“WHO, working with its partners, is committed to supporting the government of Tanzania to bring the outbreak under control as soon as possible, and to build a healthier, safer, fairer future for all the people of Tanzania,” said Dr Tedros. “Now is a time for collaboration, and commitment, to protecting the health of all people in Tanzania, and the region, from the risks posed by this disease.”

Marburg virus disease is highly virulent and causes haemorrhagic fever. It belongs to the same family as the virus that causes Ebola virus disease. Illness caused by Marburg virus begins abruptly. Patients present with high fever, severe headache and severe malaise. They may develop severe haemorrhagic symptoms within seven days.

“The declaration by the president and the measures being taken by the government are crucial in addressing the threat of this disease at the local and national levels as well as preventing potential cross-border spread,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Our priority is to support the government to rapidly scale up measures to effectively respond to this outbreak and safeguard the health of the population,”

Tanzania previously reported an outbreak of Marburg in March 2023 – the country’s first – in Kagera region, in which a total of nine cases (eight confirmed and one probable) and six deaths were reported, with a case fatality ratio of 67%.

In the African region, previous outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of the Congo, Ghana, Kenya, Equatorial Guinea, Rwanda, South Africa and Uganda.

Marburg virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials. Although several promising candidate medical countermeasures are currently undergoing clinical trials, there is no licensed treatment or vaccine for effective management or prevention of Marburg virus disease. However, early access to treatment and supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improve survival.

Source: allafrica.com

Continue Reading